Menarini Silicon Biosystems’s CELLSEARCH(R) CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination
By asianet
These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. Menarini Silicon Biosystems (MSB), Inc. [https://www.siliconbiosystems.com/en-us/] is announcing that the AMA has issued Current Procedural Terminology (CPT(R)) Proprietary Laboratory Analyses (PLA) … Continued